Bausch Health Companies Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Bausch Health Companies Inc. (BHC) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of -$802.00 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-30
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$802.00M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$1.08B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $377.00M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $356.00M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | -$802.00M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$1.08B 10-Q · filed 2026-07-30 | |
| 2025-12-31 | $377.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $356.00M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $147.00M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | -$240.00M 10-Q · filed 2026-07-30 | |
| 2024-12-31 | -$322.00M 10-Q · filed 2026-07-30 | |
| 2024-09-30 | -$242.00M 10-Q · filed 2025-10-30 | |
| 2024-06-30 | -$227.00M 10-Q · filed 2025-10-30 | |
| 2024-03-31 | -$174.00M 10-Q · filed 2025-07-31 | |
| 2023-12-31 | -$82.00M 10-K · filed 2026-02-19 | |
| 2023-09-30 | -$235.00M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $271.00M 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $145.00M 10-Q · filed 2024-08-01 | |
| 2022-12-31 | $260.00M 10-K · filed 2026-02-19 | |
| 2022-09-30 | $433.00M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $253.00M 10-Q · filed 2023-11-02 | |
| 2022-03-31 | -$141.00M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | -$34.00M 10-K · filed 2025-02-20 | |
| 2021-09-30 | -$135.00M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$611.00M 10-Q · filed 2022-11-03 | |
| 2021-03-31 | -$124.00M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $605.00M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $655.00M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $546.00M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $790.00M 10-Q · filed 2021-08-03 | |
| 2019-12-31 | $1.14B 10-K · filed 2023-02-23 | |
| 2019-09-30 | $2.56B 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $2.69B 10-Q · filed 2020-11-03 | |
| 2019-03-31 | $2.78B 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $2.81B 8-K · filed 2022-05-11 | |
| 2018-09-30 | $3.24B 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $3.56B 10-Q · filed 2019-11-04 | |
| 2018-03-31 | $4.63B 10-Q · filed 2019-08-06 | $4.52B 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.94B 8-K · filed 2021-05-04 | |
| 2017-09-30 | $5.42B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $4.03B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $3.99B 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.26B 10-K · filed 2020-02-19 | |
| 2016-09-30 | $4.27B 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $5.40B 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $5.78B 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $6.03B 10-K · filed 2019-02-20 | $6.03B 10-K · filed 2016-04-29 |
| 2015-09-30 | $6.46B 10-Q · filed 2016-11-09 | $6.46B 10-Q · filed 2015-10-26 |
| 2015-06-30 | $6.55B 10-Q · filed 2016-08-09 | $6.56B 10-Q · filed 2015-07-28 |
| 2015-03-31 | $6.57B 10-Q · filed 2016-06-07 | $6.58B 10-Q · filed 2015-04-30 |
| 2014-12-31 | $5.40B 8-K · filed 2018-08-10 | $5.43B 10-K · filed 2015-02-25 |
| 2014-09-30 | $5.23B 10-Q · filed 2015-10-26 | |
| 2014-06-30 | $5.37B 10-Q · filed 2015-07-28 | |
| 2014-03-31 | $5.20B 10-Q · filed 2015-04-30 | |
| 2013-12-31 | $5.23B 10-K · filed 2017-03-01 | $5.23B 10-K · filed 2014-02-28 |
| 2013-09-30 | $5.06B 10-Q · filed 2014-10-24 | $5.06B 10-Q · filed 2013-11-01 |
| 2013-06-30 | $5.70B 10-Q · filed 2014-08-01 | $5.70B 10-Q · filed 2013-08-07 |
| 2013-03-31 | $3.59B 10-Q · filed 2014-05-09 | $3.59B 10-Q · filed 2013-05-03 |
| 2012-12-31 | $3.72B 10-K · filed 2016-04-29 | $3.72B 10-Q · filed 2013-05-03 |
| 2012-09-30 | $3.73B 10-Q · filed 2013-11-01 | $3.79B 10-Q · filed 2012-11-05 |
| 2012-06-30 | $3.63B 10-Q · filed 2013-08-07 | $3.70B 10-Q · filed 2012-08-03 |
| 2012-03-31 | $4.02B 10-Q · filed 2013-05-03 | $4.08B 10-Q · filed 2012-05-04 |
| 2011-12-31 | $3.93B 10-Q · filed 2013-11-01 | $4.01B 10-K · filed 2012-02-29 |
| 2011-09-30 | $4.01B 10-Q · filed 2012-11-05 | |
| 2011-06-30 | $4.67B 10-Q · filed 2012-08-03 | |
| 2011-03-31 | $4.71B 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $4.91B 10-Q · filed 2012-11-05 | |
| 2010-09-30 | $5.35B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $1.36B 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $1.35B 10-K · filed 2012-02-29 | |
| 2008-12-31 | $1.20B 10-K · filed 2012-02-29 | |
| 2007-12-31 | $1.30B 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |